Becker's Healthcare October 31, 2024
The ever-rising popularity of GLP-1 medications is reshaping the landscape of bariatric surgeries — but experts say patients could be overlooking key factors when choosing between the two weight loss treatments.
Interest in GLP-1s surged in late 2022, fueled by TikTok weight loss trends and free celebrity endorsements. By early 2023, surgeons from various specialties began seeing how GLP-1s were affecting their practices.
“Everybody is either on it or asking how to get on it,” New York City dermatologist Paul Jarrod Frank, MD, told The New York Times. “We haven’t seen a prescription drug with this much cocktail and dinner chatter since Viagra came to the market.”
As Ozempic became a household name, the number of bariatric surgeries declined.
...Today's Sponsors
Today's Sponsor